期刊文献+

氟伐他汀对同型半胱氨酸诱导的凝集素样氧化低密度脂蛋白受体-1表达的影响

Effect of fluvastatin on lectin-like oxidized low-density lipoprotein receptor-1 expression induced by homocysteine in human umbilical vein endothelial cells
下载PDF
导出
摘要 目的探讨氟伐他汀对同型半胱氨酸(Hcy)诱导的人脐静脉内皮细胞(HUVECs)凝集素样氧化低密度脂蛋白受体-1(LOX-1)信使核糖核酸(m RNA)表达的影响。方法分离培养HUVECs,分为正常对照组、Hcy刺激组:100μmol/L Hcy与细胞孵育24 h,3种不同浓度的氟伐他汀干预组:分别以不同浓度的氟伐他汀(0.1、1、10μmol/L)预孵育细胞24 h,再与100μmol/L Hcy共同培养24 h,应用逆转录-聚合酶链反应(RT-PCR)检测LOX-1 m RNA的表达。结果 Hcy显著诱导HUVECs LOX-1 m RNA的表达,氟伐他汀抑制Hcy诱导的LOX-1 m RNA的表达,并呈现一定剂量依赖性。结论 Hcy可能通过LOX-1介导其内皮损伤作用,氟伐他汀可能通过减少LOX-1过度表达发挥其抗动脉粥样硬化作用。 Objective To investigate the effect of fluvastatin on the expression of LOX-1 induced by homocysteine (Hcy) in cultured human umbilical vein endothelial cells (HUVECs). Methods Human umbilical vein endothelial ceils were cultured and treated with Hcy (100μmol/L for 24 hours) alone, or pre-treated with fluvastatin (0.1, 1 or 10 μmol/L for 24 h), followed by Hcy treatment. After respective treatment, the expression of lectin-like ox-LDL receptor-1 (LOX-1) was measured by reverse transcription-polymerase chain reaction (RT-PCR). Results Hcy (100 umol/L) treatment up regulated the expression of LOX-1 in HUVECs. Pretreatment of HUVECs with fluvastatin (0.1, 1 or 10 μmol/L) de- crease Hcy-induced expression of LOX-1. A high concentration of fluvastatin (10 umol/L) was more potent than the lower concentration (1 μmol/L). Conclusion These observations indicate that endothelial dysfunction elicited by Hcy- may beassociated with an increase of LOX-1 expression. Inhibition of expression of LOX-1 may be another mechanism of beneficial effects of statins in vascular diseases.
出处 《中国医药导报》 CAS 2016年第18期169-172,共4页 China Medical Herald
关键词 氟伐他汀 凝集素样氧化低密度脂蛋白受体-1 同型半胱氨酸 内皮细胞 动脉粥样硬化 Fluvastatin Lectin-like oxidized low-density lipoprotein receptor-I Homocysteine Endothelial cells Atherosclerosis
  • 相关文献

二级参考文献38

  • 1张林华,刘秉文.一次性密度梯度超速离心分离人血清脂蛋白[J].生物化学与生物物理学报,1989,21(3):257-260. 被引量:116
  • 2Chen J,Mehta JL.Role of oxidative stress in coronary heart disease.Indian Heart J 2004; 56:163-173.
  • 3Ranganathan S,Joseph J,Mehta JL.Aspirin inhibits human coronary artery endothelial cell proliferation by upregulation of p53.Biochem Biophys Res Commun 2003; 301:143-146.
  • 4Mehta JL.Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects.Clin Cardiol 1998; 21:879-884.
  • 5Mehta JL,Chen J,Yu F,Li DY.Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-l in human coronary endothelial cells.Cardiovasc Res 2004; 64:243-249.
  • 6Costanzo A,Moretti F,Burgio VL,Bravi C,Guido F,Levrero M,et al.Endothelial activation by angiotensin Ⅱ through NF kappaB and p38 pathways:Involvement of NF kappaB-inducible kinase (NIK),free oxygen radicals,and selective inhibition by aspirin.J Cell Physiol 2003; 195:402-410.
  • 7Yuan M,Konstantopoulos N,Lee J,Hansen L,Li ZW,Karin M,et al.Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.Science 2001; 293:1673-1677.
  • 8Bocan TM.Pleiotropic effects of HMG-CoA reductase inhibitors.Curr Opin Invest Drugs 2002; 3:1312-1317.
  • 9Mason RP,Walter MF,Day CA,Jacob RF.Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.Am J Cardiol 2005; 96:11-23.
  • 10Li D,Chen H,Romeo F,Sawamura T,Mehta JL.Statins modulate oxidized iow-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells:role of LOX-1.J Phannacol Exp Ther 2002; 302:601-605.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部